Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.130
-0.080 (-6.61%)
At close: Jan 21, 2026, 4:00 PM EST
1.160
+0.030 (2.65%)
After-hours: Jan 21, 2026, 4:51 PM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $155.58 million as of January 21, 2026. Its market cap has increased by 253.41% in one year.
Market Cap
155.58M
Enterprise Value
137.05M
1-Year Change
253.41%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $155.58M, a decrease of -69.74%. That is a compound annual growth rate of -24.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 166.60M | 11.01% |
| Dec 31, 2025 | 150.07M | 230.61% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |